U-Blot® Research Grade AdalimumabCat. No. WA1024Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade AdalimumabCat. No. WA1024
U-Blot® Research Grade AdakitugCat. No. WA1023
U-Blot® Research Grade ActoxumabCat. No. WA1022
U-Blot® Research Grade AcrixolimabCat. No. WA1021
U-Blot® Research Grade acinterferon alfaCat. No. WA1020
U-Blot® Research Grade AcimtamigCat. No. WA1019
U-Blot® Research Grade AcazicolceptCat. No. WA1018
U-Blot® Research Grade AcasunlimabCat. No. WA1017
U-Blot® Research Grade AcapatamabCat. No. WA1016
U-Blot® Research Grade ABX-IL8Cat. No. WA1015
U-Blot® Research Grade AbrilumabCat. No. WA1014
U-Blot® Research Grade AbrezekimabCat. No. WA1013